Virtu Financial LLC Compass Therapeutics, Inc. Transaction History

Virtu Financial LLC

$1.43 Billion
Q2 2024

A detailed history of Virtu Financial LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 51,233 shares of CMPX stock, worth $81,460. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,233

Holding current value

$81,460

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 09, 2024	BUY	$1.0 - $1.85 $51,233 - $94,781	51,233 New	51,233 $51,000
Q4 2023 Feb 26, 2024	BUY	$1.4 - $1.98 $39,275 - $55,546	28,054 New	28,054 $44,000

Others Institutions Holding CMPX

# of Institutions

Shares Held

92M

Call Options Held

Put Options Held

Orbimed Advisors LLC San Diego, CA

22.4M
Shares

$35.6 Million
0.97% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

11.1M
Shares

$17.7 Million
0.04% of portfolio
Blackstone Inc New York, NY

10M
Shares

$15.9 Million
0.09% of portfolio
Black Rock Inc. New York, NY

6.61M
Shares

$10.5 Million
0.0% of portfolio
Bio Impact Capital LLC Cambridge, MA

5.64M
Shares

$8.97 Million
1.62% of portfolio

View Full List

About Compass Therapeutics, Inc.

Ticker CMPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 101,285,000
Market Cap $161M
Description
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...

More about CMPX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Account